These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30052477)

  • 1. Characterization of FGD5 Expression in Primary Breast Cancers and Lymph Node Metastases.
    Valla M; Mjønes PG; Engstrøm MJ; Ytterhus B; Bordin DL; van Loon B; Akslen LA; Vatten LJ; Opdahl S; Bofin AM
    J Histochem Cytochem; 2018 Nov; 66(11):787-799. PubMed ID: 30052477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis.
    Valla M; Engstrøm MJ; Ytterhus B; Hansen ÅK; Akslen LA; Vatten LJ; Opdahl S; Bofin AM
    Breast Cancer Res Treat; 2017 Apr; 162(2):243-253. PubMed ID: 28124285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of androgen receptors in breast cancer subtypes.
    Kraby MR; Valla M; Opdahl S; Haugen OA; Sawicka JE; Engstrøm MJ; Bofin AM
    Breast Cancer Res Treat; 2018 Nov; 172(2):283-296. PubMed ID: 30109519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Expression of CCR7 Predicts Lymph Node Metastasis and Good Prognosis in Triple Negative Breast Cancer.
    Li X; Sun S; Li N; Gao J; Yu J; Zhao J; Li M; Zhao Z
    Cell Physiol Biochem; 2017; 43(2):531-539. PubMed ID: 28930757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of FGD3 gene as prognostic factor in young breast cancer patients.
    Renda I; Bianchi S; Vezzosi V; Nori J; Vanzi E; Tavella K; Susini T
    Sci Rep; 2019 Oct; 9(1):15204. PubMed ID: 31645624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low mutation and neoantigen burden and fewer effector tumor infiltrating lymphocytes correlate with breast cancer metastasization to lymph nodes.
    Wang Z; Liu W; Chen C; Yang X; Luo Y; Zhang B
    Sci Rep; 2019 Jan; 9(1):253. PubMed ID: 30670769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
    Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
    Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal prognostic significance of sentinel lymph node metastasis in patients with cT1-2 and cN0 breast cancer.
    Shigematsu H; Nishina M; Yasui D; Hirata T; Ozaki S
    World J Surg Oncol; 2019 Feb; 17(1):41. PubMed ID: 30797231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.
    Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H
    Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.
    Snell CE; Gough M; Middleton K; Hsieh M; Furnas L; Seidl B; Gibbons K; Pyke C; Shannon C; Woodward N; Armes JE
    J Clin Pathol; 2017 Nov; 70(11):954-960. PubMed ID: 28416639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of gap junction protein--connexin 32 in lymph node metastases of human ductal breast cancer.
    Kanczuga-Koda L; Sulkowska M; Koda M; Rutkowski R; Sulkowski S
    Folia Histochem Cytobiol; 2007; 45 Suppl 1():S175-80. PubMed ID: 18292829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
    Falck AK; Fernö M; Bendahl PO; Rydén L
    World J Surg; 2010 Jul; 34(7):1434-41. PubMed ID: 20213203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor labeling indices of primary breast cancers and their regional lymph node metastases.
    Goodson WH; Ljung BM; Moore DH; Mayall B; Waldman FM; Chew K; Benz CC; Smith HS
    Cancer; 1993 Jun; 71(12):3914-9. PubMed ID: 8508357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
    Tang C; Wang P; Li X; Zhao B; Yang H; Yu H; Li C
    PLoS One; 2017; 12(8):e0182953. PubMed ID: 28806399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer.
    Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
    Arch Surg; 1993 Feb; 128(2):242-6. PubMed ID: 8094282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of expression of stromal cell derived factor 1 and CXCR4 in invasive breast cancer].
    Liu FF; Wei J; Lang RG; Fan Y; Cui LF; Gu F; Fu L
    Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):529-35. PubMed ID: 19094464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of 6 common antigenic markers in invasive ductal breast carcinoma: potential clinical implications.
    Lialiaris TS; Kouskoukis A; Georgiou G; Tripsianis G; Fiska A; Giatromanolaki A; Chrisafi S; Sivridis E; Vamvakopoulou DN; Soutopoulou DO; Kiritsaka A; Athanassiou E; Lialios GA; Sotiriou S; Sidiropoulos A; Vamvakopoulos NC
    Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):106-11. PubMed ID: 20724920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
    Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
    J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between HER2 Expression and Other Prognostic Factors in Breast Cancer: Inverse Relations with the Ki-67 Index and P53 Status.
    Payandeh M; Shahriari-Ahmadi A; Sadeghi M; Sadeghi E
    Asian Pac J Cancer Prev; 2016; 17(3):1015-8. PubMed ID: 27039719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.